Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Short Interest Down 75.0% in September

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) saw a large drop in short interest in September. As of September 15th, there was short interest totaling 100 shares, a drop of 75.0% from the August 31st total of 400 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 1.0 days. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 1.0 days.

Santhera Pharmaceuticals Price Performance

Shares of OTCMKTS SPHDF opened at $13.32 on Thursday. Santhera Pharmaceuticals has a 1-year low of $13.32 and a 1-year high of $19.00. The stock’s 50-day moving average is $17.95 and its 200 day moving average is $16.72.

Santhera Pharmaceuticals Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).